Milestone Scientific (MLSS) Debt to Equity (2010 - 2025)

Milestone Scientific's (MLSS) quarterly Debt to Equity came in at $0.24 in Q2 2025, up 41.68% quarter-over-quarter from $0.17 in Q2 2013.

Milestone Scientific (MLSS) Debt to Equity (2010 - 2025) Analysis & Trends

Milestone Scientific has disclosed Debt to Equity across 5 years of filings, most recently posting $0.24 for Q2 2025.

Debt to Equity for Q2 2025 came in at $0.24, changed N/A year-over-year; the trailing twelve-month figure through Jun 2025 was $0.24 (changed N/A YoY), and the FY2012 annual result was $0.23, up 0.67% from the prior year.
Debt to Equity came in at $0.24 for Q2 2025 at Milestone Scientific, up from $0.17 in the prior quarter.
In the past five years, Debt to Equity ranged from a high of $0.24 in Q2 2025 to a low of $0.24 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt/Equity (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn	-
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn	0.72
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn	1.12
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn	0.04
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn	0.07
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn	1.02
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn	0.30
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn	-
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn	1.57
10	Milestone Scientific	28.92 Mn	27.73 Mn	1.56 Mn	-

Download Data